Bayer slams Indian government, Cipla on Nexavar copies

Bayer won't let Nexavar go gently into the Indian generics pool. Since the Indian government yanked its exclusivity on the cancer drug, allowing domestic player Natco Pharma to launch a competing vers…
Read the full story: News